Jason B. Shandell - Net Worth and Insider Trading

Jason B. Shandell Net Worth

The estimated net worth of Jason B. Shandell is at least $7 Million dollars as of 2024-11-12. Jason B. Shandell is the President and General Counsel of Amphastar Pharmaceuticals Inc and owns about 138,898 shares of Amphastar Pharmaceuticals Inc (AMPH) stock worth over $7 Million. Details can be seen in Jason B. Shandell's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jason B. Shandell has not made any transactions after 2020-02-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Jason B. Shandell

Jason B. Shandell Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jason B. Shandell owns 1 companies in total, including Amphastar Pharmaceuticals Inc (AMPH) .

Click here to see the complete history of Jason B. Shandell’s form 4 insider trades.

Insider Ownership Summary of Jason B. Shandell

Ticker	Comapny	Transaction Date	Type of Owner
AMPH	Amphastar Pharmaceuticals Inc	2020-02-07	director & President

Jason B. Shandell Latest Holdings Summary

Jason B. Shandell currently owns a total of 1 stock. Jason B. Shandell owns 138,898 shares of Amphastar Pharmaceuticals Inc (AMPH) as of February 7, 2020, with a value of $7 Million.

Latest Holdings of Jason B. Shandell

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
AMPH	Amphastar Pharmaceuticals Inc	2020-02-07	138,898	48.58	6,747,665

Holding Weightings of Jason B. Shandell

Jason B. Shandell Form 4 Trading Tracker

According to the SEC Form 4 filings, Jason B. Shandell has made a total of 3 transactions in Amphastar Pharmaceuticals Inc (AMPH) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Amphastar Pharmaceuticals Inc is the sale of 44,401 shares on February 7, 2020, which brought Jason B. Shandell around $876,920.

Insider Trading History of Jason B. Shandell

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jason B. Shandell Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jason B. Shandell Ownership Network

Ownership Network List of Jason B. Shandell

No Data

Ownership Network Relation of Jason B. Shandell

Jason B. Shandell Owned Company Details

What does Amphastar Pharmaceuticals Inc do?

Who are the key executives at Amphastar Pharmaceuticals Inc?

Jason B. Shandell is the director & President of Amphastar Pharmaceuticals Inc. Other key executives at Amphastar Pharmaceuticals Inc include CFO & SVP & Treasurer William J Peters , SVP Corp Admin Center Yakob Liawatidewi , and EVP & Production Rong Zhou .

Amphastar Pharmaceuticals Inc (AMPH) Insider Trades Summary

Over the past 18 months, Jason B. Shandell made no insider transaction in Amphastar Pharmaceuticals Inc (AMPH). Other recent insider transactions involving Amphastar Pharmaceuticals Inc (AMPH) include a net sale of 15,500 shares made by Floyd F. Petersen , a net sale of 180,933 shares made by William J Peters , and a net sale of 34,830 shares made by Rong Zhou .

In summary, during the past 3 months, insiders sold 22,640 shares of Amphastar Pharmaceuticals Inc (AMPH) in total and bought 0 shares, with a net sale of 22,640 shares. During the past 18 months, 687,521 shares of Amphastar Pharmaceuticals Inc (AMPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 687,521 shares.

Amphastar Pharmaceuticals Inc (AMPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

Amphastar Pharmaceuticals Inc Insider Transactions

No Available Data

Jason B. Shandell Mailing Address

Above is the net worth, insider trading, and ownership report for Jason B. Shandell. You might contact Jason B. Shandell via mailing address: 11570 6th Street, Rancho Cucamonga Ca 91730.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.